-
2
-
-
42149103046
-
-
World Health Organization
-
World Health Organization (2006) Facts on ACTs (artemisinin based combinations). http://www.rollbackmalaria.org/cmc_upload/0/000/15/364/ RBMinfosheet_9.pdf
-
(2006)
Facts on ACTs (Artemisinin Based Combinations)
-
-
-
3
-
-
44449129845
-
Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers
-
C Orrell F Little P Smith P Folb W Taylor P Olliaro 2008 Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers Eur J Clin Pharmacol 64 683 690
-
(2008)
Eur J Clin Pharmacol
, vol.64
, pp. 683-690
-
-
Orrell, C.1
Little, F.2
Smith, P.3
Folb, P.4
Taylor, W.5
Olliaro, P.6
-
6
-
-
34147129728
-
Lack of impact of artesunate on the disposition kinetics of sulfadoxine/pyrimethamine when the two drugs are concomitantly administered
-
5
-
OM Minzi A Gupta AF Haule GA Kagashe AY Massele LL Gustafsson 2007 Lack of impact of artesunate on the disposition kinetics of sulfadoxine/pyrimethamine when the two drugs are concomitantly administered Eur J Clin Pharmacol 63 5 457 462
-
(2007)
Eur J Clin Pharmacol
, vol.63
, pp. 457-462
-
-
Minzi, O.M.1
Gupta, A.2
Haule, A.F.3
Kagashe, G.A.4
Massele, A.Y.5
Gustafsson, L.L.6
-
8
-
-
34248180608
-
Effects of prior administration of amodiaquine on the disposition of halofantrine in healthy volunteers
-
2
-
SI Omoruvi CO Onyeji MO Daniyan 2007 Effects of prior administration of amodiaquine on the disposition of halofantrine in healthy volunteers Ther Drug Monit 29 2 203 206
-
(2007)
Ther Drug Monit
, vol.29
, pp. 203-206
-
-
Omoruvi, S.I.1
Onyeji, C.O.2
Daniyan, M.O.3
-
9
-
-
34447569316
-
Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: Implications for malaria treatment in Africa
-
2
-
S Parikl JB Ouedragog JA Goldstein PJ Rosenthal DL Kroetz 2007 Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa Clin Pharmacol Ther 82 2 197 203
-
(2007)
Clin Pharmacol Ther
, vol.82
, pp. 197-203
-
-
Parikl, S.1
Ouedragog, J.B.2
Goldstein, J.A.3
Rosenthal, P.J.4
Kroetz, D.L.5
-
10
-
-
0036154008
-
Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: A new high affinity and turnover enzyme-specific probe substrate
-
2
-
XQ Li A Bjorkman TB Andersson M Ridderstrom CM Masimirembwa 2002 Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate J Pharmacol Exp Ther 300 2 399 407
-
(2002)
J Pharmacol Exp Ther
, vol.300
, pp. 399-407
-
-
Li, X.Q.1
Bjorkman, A.2
Andersson, T.B.3
Ridderstrom, M.4
Masimirembwa, C.M.5
-
11
-
-
0141483123
-
Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data
-
5-6
-
XQ Li A Bjorkman TB Andersson LL Gustafsson CM Masimirembwa 2003 Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data Eur J Clin Pharmacol 59 5-6 429 442
-
(2003)
Eur J Clin Pharmacol
, vol.59
, pp. 429-442
-
-
Li, X.Q.1
Bjorkman, A.2
Andersson, T.B.3
Gustafsson, L.L.4
Masimirembwa, C.M.5
-
12
-
-
33745727111
-
Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D) and losartan (CYP2C9) in vivo
-
7
-
A Wennerholm A Nordmark M Pihlsgard M Mahindi L Bertilsson LL Gustafsson 2006 Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D) and losartan (CYP2C9) in vivo Eur J Clin Pharmacol 62 7 539 546
-
(2006)
Eur J Clin Pharmacol
, vol.62
, pp. 539-546
-
-
Wennerholm, A.1
Nordmark, A.2
Pihlsgard, M.3
Mahindi, M.4
Bertilsson, L.5
Gustafsson, L.L.6
-
15
-
-
38149059991
-
Clinical pharmacology of artemisinin-based combination therapies
-
2
-
PI German FT Aweeka 2008 Clinical pharmacology of artemisinin-based combination therapies Clin Pharmacokinet 42 2 91 102
-
(2008)
Clin Pharmacokinet
, vol.42
, pp. 91-102
-
-
German, P.I.1
Aweeka, F.T.2
-
16
-
-
14844334573
-
Pharmacodynamic interactions of amodiaquine and its major metabolite desethylamodiaquine with artemisinin, quinine and atovaquone in Plasmodium falciparum in vitro
-
3
-
ST Mariga JP Gil WH Wernsdorfer A Bjorkman 2005 Pharmacodynamic interactions of amodiaquine and its major metabolite desethylamodiaquine with artemisinin, quinine and atovaquone in Plasmodium falciparum in vitro Acta Trop 93 3 221 231
-
(2005)
Acta Trop
, vol.93
, pp. 221-231
-
-
Mariga, S.T.1
Gil, J.P.2
Wernsdorfer, W.H.3
Bjorkman, A.4
-
17
-
-
20444387955
-
Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadioxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan
-
6
-
N Durrani T Leslie S Rahim K Graham F Ahmad M Rowland 2005 Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadioxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan Trop Med Int Health 10 6 521 529
-
(2005)
Trop Med Int Health
, vol.10
, pp. 521-529
-
-
Durrani, N.1
Leslie, T.2
Rahim, S.3
Graham, K.4
Ahmad, F.5
Rowland, M.6
-
18
-
-
38449094920
-
Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Sénégal
-
P Brasseur P Agnamey O Gaye M Vaillant WR Taylor PL Olliaro 2007 Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Sénégal Malaria J 6 150
-
(2007)
Malaria J
, vol.6
, pp. 150
-
-
Brasseur, P.1
Agnamey, P.2
Gaye, O.3
Vaillant, M.4
Taylor, W.R.5
Olliaro, P.L.6
|